共 60 条
[1]
Guzick DS(2004)Polycystic ovary syndrome Obstet Gynecol 103 181-193
[2]
Azziz R(2004)The prevalence and features of the polycystic ovary syndrome in an unselected population J Clin Endocrinol Metab 89 2745-2749
[3]
Woods KS(2004)Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome Fertil Steril 81 19-25
[4]
Reyna R(2000)Ovulation induction with urinary follicle stimulating hormone versus human menopausal gonadotropin for clomiphene-resistant polycystic ovary syndrome Cochrane Database Syst Rev 2 CD000087-2051
[5]
Key TJ(2005)Clomiphene citrate—end of an era? A mini-review Hum Reprod 20 2043-274
[6]
Knochenhauer ES(2008)Polycystic ovary syndrome Best Pract Res Clin Obstet Gynaecol 22 261-278
[7]
Yildiz BO(2006)Polycystic ovarian syndrome—prognosis and outcomes Best Pract Res Clin Obstet Gynaecol 20 251-4800
[8]
Hughes E(2004)Editorial: metformin—comparison with other therapies in ovulation induction in polycystic ovary syndrome J Clin Endocrinol Metab 89 4797-667
[9]
Collins J(2003)Insulin-lowering agents in the management of polycystic ovary syndrome Endocr Rev 24 633-800
[10]
Vandekerckhove P(1997)Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis Endocr Rev 18 774-793